Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

iBio Inc. (IBIO)

  • Business News
  • June 24, 2025, 11:01 UTC

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

Full text
Register to leave comments
There are no comments here yet...

Search

News categories

  • Technical Exchange News(9492)
  • Event(407)
  • SEC News(155863)
  • FDA Approval(8880)
  • Company Report(721)
  • Business News(105748)
© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin